|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 |
| (11) | Patento numeris | 2870261 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13735529.3 |
| Europos patento paraiškos padavimo data | 2013-06-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-05-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-12-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/047925 |
| Data | 2013-06-26 |
| (87) | Numeris | WO 2014/011398 |
| Data | 2014-01-16 |
| (30) | Numeris | Data | Šalis |
| 201261669534 P | 2012-07-09 | US |
| (72) |
CAPONIGRO, Giordano, US
DELACH, Scott, US
GARRAWAY, Levi, US
JAGANI, Zainab, US
KIM, Sunkyu, US
KRYUKOV, Gregory, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
Dana-Farber Cancer Institute, Inc., 450 Brookline Avenue, Boston, MA 02215-5450, US Broad Institute, 44 Binney Street, Boston, Massachusetts 02115, US |
| (54) | BIOMARKERS ASSOCIATED WITH CDK INHIBITORS |
| BIOMARKERS ASSOCIATED WITH CDK INHIBITORS |